Efficacy and safety of ongericimab given by prefilled syringe or autoinjector in primary hypercholesterolemia and mixed hyperlipidemia

This study aimed to evaluate the efficacy and safety of ongericimab administered by prefilled syringe (PFS) or autoinjector (AI) in Chinese patients with primary hypercholesterolemia and mixed dyslipidemia on stable optimized lipid-lowering therapy.

Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - April 23, 2024 Category: Nutrition Authors: Wang Zhao, Zhifeng Cheng, Xianyou Ji, Zhaohui Pei, Keping Yang, Zhouqing Huang, Yanqing Wu, Gaopin Wang, Minghui Wang, Yi Zhao, Xuelian Bai, Shuiping Zhao Source Type: research